RUBELLA VIRUS - ANVISA Registration 10345162376
Access comprehensive regulatory information for RUBELLA VIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10345162376 and manufactured by manufacturer not specified. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until Aug 10, 2030.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT IRELAND DIAGNOSTIC DIVISION, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
10345162376
25351215984202024
01449930000190
Company Information
Dates and Status
Aug 10, 2020
10/08/2030
09/18/2025 19:00:01
ROCHE DIAGNOSTICS GMBH• Germany
ABBOTT IRELAND DIAGNOSTIC DIVISION• Ireland
QUIBASA QUÍMICA BÁSICA LTDA• Brazil
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD.• United Kingdom
SIEMENS HEALTHCARE DIAGNOSTICS INC.• United States of America
VÍRUS DE RUBÉOLA
BIOLISA RUBÉOLA IgM
QUIBASA QUÍMICA BÁSICA LTDA
10269360465
Jun 09, 2025
VÍRUS DE RUBÉOLA
BIOLISA RUBÉOLA IgG
QUIBASA QUÍMICA BÁSICA LTDA
10269360464
Jun 09, 2025
VÍRUS DE RUBÉOLA
IMUNOSCREEN RUBÉOLA IGM DBS
MBIOLOG DIAGNOSTICOS LTDA
80047580226
May 19, 2025
VÍRUS DE RUBÉOLA
Micropartículas Rubéola IgM (CLIA)
Not specified
80102513382
Feb 24, 2025
VÍRUS DE RUBÉOLA
Micropartículas de Rubéola IgG (CLIA)
AUTOBIO DIAGNOSTICS CO., LTD
80102513381
Feb 24, 2025

